Advertisement

Head and Neck Pathology

, Volume 4, Issue 3, pp 210–213 | Cite as

Nasopharyngeal Angiofibroma of the Nasal Cavity

  • S. Marc Stokes
  • James T. CastleEmail author
Sine qua none Radiology-Pathology

History

A 13 year-old male with a chief complaint of recurrent epistaxis is shown to have a pearly white mass in right nasal cavity on physical exam.

Radiographic Features

Computed tomography scans and magnetic resonance imaging studies are currently the mainstay for diagnosis and aid in delineating the extent of tumor and degree of surrounding tissue destruction. An anterior bowing of the posterior wall of the maxillary sinus, the “antral bowing sign,” can be identified in most patients. Other commonly seen radiographic changes include widening of the inferolateral aspect of the superior orbital fissure, distortion of the pterygoid plates, erosion of the hard palate, disruption of the medial wall of maxillary sinus, and displacement of the nasal septum.

In the current case, visualization of an axial T2 weighted magnetic resonance image demonstrated an intermediate to high signal, well-circumscribed mass noted in the right nasal cavity and chonca at the level of the condyles which...

Keywords

Nasal Cavity Maxillary Sinus Chordoma Solitary Fibrous Tumor Infratemporal Fossa 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

We acknowledge and appreciate the radiographic interpretation expertise of Dr. Ann Monasky.

Disclaimer

The opinions and assertions expressed herein are those of the authors and are not to be construed as official or representing the views of the Department of the Navy or the Department of Defense.

References

  1. 1.
    Batsakis JG. Tumors of the head and neck: clinical and pathological considerations. 2nd ed. Baltimore: Williams & Wilkins; 1979. p. 296–300.Google Scholar
  2. 2.
    Neel HB, Whicker JH, Devine KD, Weiland JH. Juvenile angiofibroma: review of 120 cases. Am J Surg. 1973;126:547–56.CrossRefPubMedGoogle Scholar
  3. 3.
    Hwang HC, Mills SE, Patterson K, et al. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11:122–1126.Google Scholar
  4. 4.
    Lee DA, Rao BR, Meyer JS, et al. Hormonal receptor determination in juvenile nasopharyngeal angiofibromas. Cancer. 1980;46:547–51.CrossRefPubMedGoogle Scholar
  5. 5.
    Johns ME, MacLeod RM, Cantrell RW. Estrogen receptors in nasopharyngeal angiofibromas. Laryngoscope. 1980;90:628–34.CrossRefPubMedGoogle Scholar
  6. 6.
    Hyams VJ. Tumors of the upper respiratory tract: vascular tumors. In: Hyams VJ, Batsakis JG, Micheals L, editors. Atlas of tumor pathology, 2nd series. Washington, DC: Armed Forces Institute of Pathology; 1986. p. 130–45.Google Scholar
  7. 7.
    Fagan JJ, Snyderman CH, Carrau RL, Janecka IP. Nasopharyngeal angiofibromas: selecting a surgical approach. Head Neck. 1997;19:391–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Unganont K, Byers RM, Weber RS, Callender DL, Wolf PE, Goepfer H. Juvenile nasopharyngeal angiofibroma: an update of therapeutic management. Head Neck. 1996;18:60–6.CrossRefGoogle Scholar
  9. 9.
    Kamel RH. Transnasal endoscopic surgery in juvenile nasopharyngeal angiofibromas. J Laryngol Otol. 1996;110:962–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Beham A, Beham-Schmid C, Regauer S, Aubock L, Stammberger H. Nasopaharyngeal angiofibroma: true neoplasm or vascular neoplasm. Adv Anat Pathol. 2000;7:36–46.CrossRefPubMedGoogle Scholar
  11. 11.
    Beham A, Fletcher CDM, Kainz J, et al. Nasopharyngeal angiofibroma: an immunohistochemical study of 32 cases. Virchows Arch A Pathol Anat Histopathol. 1993;423:281–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Witt TR, Shah JP, Sternberg SS. Juvenile nasopharyngeal angiofibromas: a 30 year clinical review. Am J Surg. 1983;146:521–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Neville BW, Damm DD, Allen CM, Bouqout JE. Oral and maxillofacial pathology. St. Louis: WB Saunders Company; 2009. p. 692–5.Google Scholar
  14. 14.
    Wanamaker JR, Lavertu P, Levine HL. Juvenile angiofibroma. In: Kraus DH, Levine HL, editors. Nasal neoplasia. New York: Thieme; 1997. p. 61–84.Google Scholar
  15. 15.
    Bales C, Kotapka M, Loever LA, Al-Rawi M, Weinstein G, Hurst R, Weber RS. Craniofacial resection of advanced juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg. 2002;128:1071–8.PubMedGoogle Scholar
  16. 16.
    Margalit N, Wasserzug O, De-Row A, Abergel A, Fliss DM, Gil Z. Surgical treatment of juvenile nasopharyngeal angiofibroma with intracranial extension. Clinical article. J Neurosurg Pediatr. 2009;4(2):113–7.CrossRefGoogle Scholar
  17. 17.
    Chen KTK, Bauer FW. Sarcomatous transformation of nasopharyngeal angiofibroma. Cancer. 1982;49:369–71.CrossRefPubMedGoogle Scholar
  18. 18.
    Batsakis JG, Klopp CT, Newman W. Fibrosarcoma arising in a “juvenile” nasopharyngeal angiofribroma following extensive radiation therapy. Am Surg. 1955;21:786–93.PubMedGoogle Scholar
  19. 19.
    Janaki MG, Nimala S, Rajeev AG. Nasopharyngeal angiofibroma treated with radiotherapy. J Cancer Res Ther. 2007;3(2):100–1.CrossRefPubMedGoogle Scholar
  20. 20.
    Goepfert H, Cangi A, Lee Y-Y. Chemotherapy for aggressive juvenile nasopharyngeal angiofibroma. Arch Otolaryngol. 1985;111:285–9.PubMedGoogle Scholar
  21. 21.
    McGavran MH, Sessions DG, Dorfman RF, et al. Nasopharyngeal angiofibroma. Arch Otolaryngol. 1969;90:68–78.PubMedGoogle Scholar

Copyright information

© US Government 2010

Authors and Affiliations

  1. 1.Department of Oral & Maxillofacial PathologyNaval Postgraduate Dental School, NMMPT&EBethesdaUSA

Personalised recommendations